These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 5781077)

  • 1. Assay of antilymphocyte serum by inhibition of circulating lymphocyte activity.
    Pattisson PH; Allman V; Boak JL
    Br J Surg; 1969 May; 56(5):387. PubMed ID: 5781077
    [No Abstract]   [Full Text] [Related]  

  • 2. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.
    Waltman SR; Burde RM; Faulkner HW
    Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328
    [No Abstract]   [Full Text] [Related]  

  • 3. Antilymphocyte serum: summary and further observations.
    Woodruff MF
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present status of anti-lymphocyte serum and its problems].
    Fujimoto Y
    Geka Chiryo; 1969 Jul; 21(1):86-91. PubMed ID: 4901874
    [No Abstract]   [Full Text] [Related]  

  • 5. Notes on the preparation and assay of anti-lymphocytic serum for use in mice.
    Jooste SV; Lance EM; Levey RH; Medawar PB; Ruszkiewicz M; Sharman R; Taub RN
    Immunology; 1968 Nov; 15(5):697-705. PubMed ID: 4880356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of immunosuppressive activity in antilymphocyte sera.
    Clayman JA; Sloss A; Hubay CA; Cohen C; Powell AE
    Surg Forum; 1969; 20():248-9. PubMed ID: 4986401
    [No Abstract]   [Full Text] [Related]  

  • 7. Assay for the immunosuppressive capacity of antilymphocyte serum. 3. Opsonizing activity of anti-human lymphocyte serum.
    Martin WJ
    J Immunol; 1969 Nov; 103(5):1000-5. PubMed ID: 5350963
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR; Faulkner HW; Burde RM
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of specific, potent antilymphocyte serum in the horse using dog thymocytes.
    Braf ZF; Smellie WA; Williams GM; Hume DM
    Surg Forum; 1967; 18():227-9. PubMed ID: 4866923
    [No Abstract]   [Full Text] [Related]  

  • 10. The place of heterologous antilymphocytic globulin in renal transplantation.
    Clunie GJ
    Med J Aust; 1969 Jun; 1(26):1368-70. PubMed ID: 4898052
    [No Abstract]   [Full Text] [Related]  

  • 11. [The anti-lymphocyte serum].
    Halpern B
    Rev Fr Odontostomatol; 1969 Apr; 16(4):515-22. PubMed ID: 4184525
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antilymphocyte serum].
    van Bekkum DW
    Ned Tijdschr Geneeskd; 1969 Jan; 113(1):22-8. PubMed ID: 4973960
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
    Wagner JL; Haughton G
    J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191
    [No Abstract]   [Full Text] [Related]  

  • 14. An in vitro correlative assay for the immunosuppressive activity of horse anti-rat lymphocyte sera: estimation of lymphocytophilic antibody activity using 51Cr-labeled thymocytes.
    Bach MK; Brashler JR; Perper RJ
    J Immunol; 1970 Sep; 105(3):746-54. PubMed ID: 4917254
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged survival of renal allografts in dogs treated with anti-lymphocyte serum.
    Abbott WM; Otherson HB; Monaco AP; Simmons RL; Russell PS; Wood ML
    Surg Forum; 1966; 17():228-30. PubMed ID: 5331809
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of heterologous antilymphocyte serum on the immunoreactivity of mice].
    Andreson RK
    Biull Eksp Biol Med; 1970 Mar; 69(3):84-7. PubMed ID: 4928082
    [No Abstract]   [Full Text] [Related]  

  • 18. [Homologous liver transplantation in the dog under immunsuppressive treatment with antilymphocytic serum].
    Pichlmayr R; Mikaéloff P; Messmer K; Rassat JP; Bomel J; Tidow G; Fateh-Moghadam A; Junghans M; Brendel W
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 146(3):261-74. PubMed ID: 4972213
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolongation of canine renal allografts by horse anti-dog lymphocyte serum and globulin.
    Diethelm AG; Busch GJ; Dubernard JM; Orr WM; Glassock RJ; Birtch AG; Murray JE
    Ann Surg; 1969 Apr; 169(4):569-77. PubMed ID: 4886852
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of anti-lymphocyte serum on the response of human and mouse lymphocytes to PHA.
    Mosedale B; Felstead KJ; Parke JA
    Nature; 1968 Jun; 218(5145):983-4. PubMed ID: 5681250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.